Free Trial
Tada emoji MarketBeat All Access — Now Just $5.00 for 5 Weeks

Labcorp (LH) Stock Forecast & Price Target

Labcorp logo
$278.06 +2.78 (+1.01%)
Closing price 03:59 PM Eastern
Extended Trading
$278.09 +0.02 (+0.01%)
As of 04:20 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.
Compare

Labcorp - Analysts' Recommendations and Stock Price Forecast (2025)

Consensus Rating

Moderate Buy
Based on 13 Analyst Ratings
Sell
1
Hold
3
Buy
9

Based on 13 Wall Street analysts who have issued ratings for Labcorp in the last 12 months, the stock has a consensus rating of "Moderate Buy." Out of the 13 analysts, 1 has given a sell rating, 3 have given a hold rating, and 9 have given a buy rating for LH.

Consensus Price Target

$290.33
4.41% Upside
According to the 13 analysts' twelve-month price targets for Labcorp, the average price target is $290.33. The highest price target for LH is $311.00, while the lowest price target for LH is $260.00. The average price target represents a forecasted upside of 4.41% from the current price of $278.07.
MarketBeat calculates consensus analyst ratings for stocks using the most recent rating from each Wall Street analyst that has rated a stock within the last twelve months. Each analyst's rating is normalized to a standardized rating score of 1 (sell), 2 (hold), 3 (buy) or 4 (strong buy). Analyst consensus ratings scores are calculated using the mean average of the number of normalized sell, hold, buy and strong buy ratings from Wall Street analysts. Each stock's consensus analyst rating is derived from its calculated consensus ratings score (0 to .5 = Strong Sell, .5 to 1 = Sell, 1 to 1.5 = Reduce, 1.5 to 2.5 = Hold, 2.5 to 3.0 = Moderate Buy, 3.0 to 3.5 = Buy, >3.5 = Strong Buy). MarketBeat's consensus price targets are a mean average of the most recent available price targets set by each analyst that has set a price target for the stock in the last twelve months. MarketBeat's consensus ratings and consensus price targets may differ from those calculated by other firms due to differences in methodology and available data.
Get the Latest News and Ratings for LH and Related Stocks

Enter your email address to receive the latest news and analysts' ratings for Labcorp and its competitors.

Sign Up
By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

LH Analyst Ratings Over Time

TypeCurrent Forecast
8/29/24 to 8/29/25		1 Month Ago
7/30/24 to 7/30/25		3 Months Ago
5/31/24 to 5/31/25		1 Year Ago
8/30/23 to 8/29/24
Strong Buy
0 Strong Buy rating(s)
0 Strong Buy rating(s)
1 Strong Buy rating(s)
0 Strong Buy rating(s)
Buy
9 Buy rating(s)
9 Buy rating(s)
10 Buy rating(s)
9 Buy rating(s)
Hold
3 Hold rating(s)
4 Hold rating(s)
3 Hold rating(s)
4 Hold rating(s)
Sell
1 Sell rating(s)
1 Sell rating(s)
0 Sell rating(s)
0 Sell rating(s)
Consensus Price Target$290.33$285.00$272.92$247.42
Forecasted Upside4.41% Upside7.95% Upside9.77% Upside7.74% Upside
Consensus Rating
Moderate Buy
Moderate Buy
Moderate Buy
Moderate Buy

LH Analyst Recommendations By Month

The chart below shows how a company's ratings by analysts have changed over time. Each bar represents the previous year of ratings for that month. Within each bar, the sell ratings are shown in red, the hold ratings are shown in yellow, the buy ratings are shown in green, and the strong buy ratings are shown in dark green.
Skip Chart & View Analyst Rating History

LH Price Targets by Month

The chart below shows how a company's share price and consensus price target have changed over time. The dark blue line represents the company's actual price. The lighter blue line represents the stock's consensus price target. The even lighter blue range in the background of the two lines represents the low price target and the high price target for each stock.
Skip Chart and View Analyst Price Target HistorySkip Chart & View Price History Table

Labcorp Stock vs. The Competition

TypeLabcorpMedical CompaniesS&P 500
Consensus Rating Score
2.62
2.78
2.53
Consensus RatingModerate BuyModerate BuyModerate Buy
Predicted Upside4.98% Upside15,720.85% Upside10.25% Upside
News Sentiment Rating
Positive News

See Recent LH News
Positive News
Positive News
Export to Excel
DateBrokerageAnalyst NameActionRatingPrice TargetUpside/Downside on Report DateDetails
8/25/2025Robert W. Baird
2 of 5 stars		Eric Coldwell
Subscribe to MarketBeat All Access for the recommendation accuracy rating		Set Target$311.00+12.07%
7/25/2025UBS Group
3 of 5 stars		Kevin Caliendo
Subscribe to MarketBeat All Access for the recommendation accuracy rating		Boost TargetBuy ➝ Buy$282.00 ➝ $305.00+15.23%
7/25/2025Truist Financial
3 of 5 stars		David MacDonald
Subscribe to MarketBeat All Access for the recommendation accuracy rating		Boost TargetBuy ➝ Buy$290.00 ➝ $310.00+17.12%
7/25/2025Evercore ISI
Subscribe to MarketBeat All Access for the recommendation accuracy rating		Elizabeth Anderson
Subscribe to MarketBeat All Access for the recommendation accuracy rating		Boost TargetOutperform ➝ Outperform$285.00 ➝ $300.00+12.22%
7/25/2025Morgan Stanley
Subscribe to MarketBeat All Access for the recommendation accuracy rating		Ricky Goldwasser
Subscribe to MarketBeat All Access for the recommendation accuracy rating		Boost TargetOverweight ➝ Overweight$283.00 ➝ $306.00+14.43%
7/10/2025Hsbc Global Res
Subscribe to MarketBeat All Access for the recommendation accuracy rating		M. Herholdt
Subscribe to MarketBeat All Access for the recommendation accuracy rating		DowngradeStrong-Buy ➝ Hold
7/10/2025HSBC
Subscribe to MarketBeat All Access for the recommendation accuracy rating		 DowngradeBuy ➝ Hold$260.00+0.21%
6/25/2025Barclays
Subscribe to MarketBeat All Access for the recommendation accuracy rating		L. Sergott
Subscribe to MarketBeat All Access for the recommendation accuracy rating		Reiterated RatingCautious ➝ Cautious
5/6/2025Piper Sandler
Subscribe to MarketBeat All Access for the recommendation accuracy rating		David Westenberg
Subscribe to MarketBeat All Access for the recommendation accuracy rating		Reiterated RatingNeutral ➝ Neutral$260.00 ➝ $280.00+13.84%
4/2/2025Redburn Atlantic
Subscribe to MarketBeat All Access for the recommendation accuracy rating		Jamie Clark
Subscribe to MarketBeat All Access for the recommendation accuracy rating		Initiated CoverageBuy$276.00+18.64%
3/4/2025Citigroup
Subscribe to MarketBeat All Access for the recommendation accuracy rating		Ralph Giacobbe
Subscribe to MarketBeat All Access for the recommendation accuracy rating		UpgradeNeutral ➝ Buy$250.00 ➝ $300.00+18.11%
2/6/2025Jefferies Financial Group
Subscribe to MarketBeat All Access for the recommendation accuracy rating		Tycho Peterson
Subscribe to MarketBeat All Access for the recommendation accuracy rating		Boost TargetBuy ➝ Buy$275.00 ➝ $290.00+17.25%
12/13/2024Bank of America
Subscribe to MarketBeat All Access for the recommendation accuracy rating		 Boost TargetBuy ➝ Buy$262.00 ➝ $271.00+16.67%
8/2/2024Deutsche Bank Aktiengesellschaft
Subscribe to MarketBeat All Access for the recommendation accuracy rating		 Boost TargetHold ➝ Hold$220.00 ➝ $230.00-2.35%
5/30/2024JPMorgan Chase & Co.
Subscribe to MarketBeat All Access for the recommendation accuracy rating		 Lower TargetOverweight ➝ Overweight$261.00 ➝ $243.00+25.49%
3/25/2024Argus
Subscribe to MarketBeat All Access for the recommendation accuracy rating		 UpgradeHold ➝ Buy$250.00+17.23%
2/26/2024Leerink Partnrs
Subscribe to MarketBeat All Access for the recommendation accuracy rating		M. Cherny
Subscribe to MarketBeat All Access for the recommendation accuracy rating		Reiterated RatingOutperform
2/26/2024Leerink Partners
Subscribe to MarketBeat All Access for the recommendation accuracy rating		 Initiated CoverageOutperform$260.00+18.63%
10/31/2023Mizuho
Subscribe to MarketBeat All Access for the recommendation accuracy rating		 Lower TargetBuy ➝ Buy$257.00 ➝ $230.00+16.07%

Analyst ratings data on MarketBeat is provided by Benzinga and other data providers. This page was last refreshed on Friday at 09:46 PM ET.


Should I Buy Labcorp Stock? LH Pros and Cons Explained

These pros and cons were generated based on recent news and financial data from MarketBeat in order to provide readers with the fastest and most accurate insights. They were last updated on Monday, August 25, 2025. Please send any questions or comments about these Labcorp pros and cons to contact@marketbeat.com.

Labcorp
Bull Case

green Wall Street bull icon

Here are some ways that investors could benefit from investing in Laboratory Co. of America Holdings:

  • The current stock price is around $259.56, reflecting a strong performance in the market.
  • Recent performance shows a significant increase of over 20% in the last year, indicating robust growth potential.
  • Institutional ownership is high, with nearly 97% of shares held by institutional investors, suggesting confidence in the company's future.
  • The average daily trading volume is substantial, providing liquidity and making it easier for investors to buy and sell shares.
  • Short interest has decreased recently, indicating that fewer investors are betting against the stock, which can be a positive sign for potential growth.

Labcorp
Bear Case

red Wall Street bear icon

Investors should be bearish about investing in Laboratory Co. of America Holdings for these reasons:

  • Despite recent growth, the stock has shown volatility, which may deter risk-averse investors.
  • The short percentage of float is around 3.32%, suggesting some investors are still skeptical about the stock's future performance.
  • There has been a notable month-to-month increase in shares shorted, indicating growing bearish sentiment among some investors.
  • Days to cover is approximately 3.7, which means it could take longer for short sellers to cover their positions, potentially leading to price fluctuations.
  • While institutional ownership is high, it also means that the stock may be more susceptible to large sell-offs if institutions decide to reduce their positions.

LH Forecast - Frequently Asked Questions

According to the research reports of 13 Wall Street equities research analysts, the average twelve-month stock price forecast for Labcorp is $290.33, with a high forecast of $311.00 and a low forecast of $260.00.

13 Wall Street equities research analysts have issued "buy," "hold," and "sell" ratings for Labcorp in the last year. There is currently 1 sell rating, 3 hold ratings and 9 buy ratings for the stock. The consensus among Wall Street equities research analysts is that investors should "moderate buy" LH shares.

According to analysts, Labcorp's stock has a predicted upside of 4.41% based on their 12-month stock forecasts.

Over the previous 90 days, Labcorp's stock had 2 downgrades by analysts.

Labcorp has been rated by research analysts at Barclays, Evercore ISI, Hsbc Global Res, HSBC, Morgan Stanley, Robert W. Baird, Truist Financial, and UBS Group in the past 90 days.

Analysts like Labcorp less than other "medical" companies. The consensus rating score for Labcorp is 2.62 while the average consensus rating score for "medical" companies is 2.78. Learn more on how LH compares to other companies.

Related Companies
Today's Ratings
Top-Rated Stocks
More Ratings Tools

This page (NYSE:LH) was last updated on 8/29/2025 by MarketBeat.com Staff
From Our Partners
INVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting Off
Right now, we’re witnessing a monumental shift in the world.
Traders Agency | Sponsoredtc pixel
BONUS GUIDE - Ben Stein Prepares For the Next Financial Crisis
With inflation high, debt soaring, and global tensions rising, a financial storm may be brewing. Economist ...
Goldco Precious Metals | Sponsoredtc pixel
This is my Christian duty
“This land I will give to you…” — a 4,000-year-old line from Genesis may hold the key to unlocking a $150 tril...
Paradigm Press | Sponsoredtc pixel
Everyone’s watching Nvidia right now. Here’s why I’m excited.
So, unless you’ve been living under a rock, you probably saw the news… Nvidia just signed a $7 BILLION deal...
Timothy Sykes | Sponsoredtc pixel
Alex’s “Next Magnificent Seven” stocks
The original “Magnificent Seven” turned $7K into $1.18 million. Now, Alex Green has identified AI’s Next Ma...
The Oxford Club | Sponsoredtc pixel
Elon’s Secret Social Security Bombshell
To All Americans Born Before April 16th, 1963: Did Trump Just Give The Green Light To Radically RE-DO Social S...
Banyan Hill Publishing | Sponsoredtc pixel
Out of 18,347 Cryptocurrencies... This is the ONLY One
The Single Most Undervalued DeFi Protocol You've Never Heard Of If there's one cryptocurrency you should b...
Crypto 101 Media | Sponsoredtc pixel
“Fed Proof” Your Bank Account with THESE 4 Simple Steps
Starting as soon as a few months from now, the United States government will make a sweeping change to bank ac...
Weiss Ratings | Sponsoredtc pixel